Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Genome Sequence of Fungus Responsible for Dandruff, Skin Disorders Completed

By Drug Discovery Trends Editor | November 6, 2007

Scientists from P&G Beauty successfully sequenced the complete genome for Malassezia globosa (M. globosa), a naturally occurring fungus responsible for the onset of dandruff and other skin conditions in humans.  Results of the genome sequencing are published in an online edition of Proceedings of the National Academy of Sciences (PNAS).  Dandruff and seborrheic dermatitis affect more than 50 percent of the human population.  Despite the role of Malassezia in these and other common skin diseases, including eczema, atopic dermatitis and psoriasis, little was known about the fungus at the molecular level until this study.  In addition, understanding of Malassezia’s genetic make-up may help scientists reevaluate the parameters that have historically been used to classify fungal organisms. 

M. globosa, which is among the smallest of the sequenced free-living fungal organisms, is comprised of just around 4,285 genes—roughly 300 times fewer base pairs than are found in the human genome.  A common fungus that lives on the skin of humans, M. globosa feeds off of fatty external lipids. Humans naturally secrete sebum and other lipids onto the scalp, creating a prime environment for M. globosa to thrive. The average human can host to up to 10 million M. globosa.  Symptoms of dandruff and seborrheic dermatitis occur when three factors come together:  genetic susceptibility for an inflammatory response, the presence of sebum on the scalp and the presence of M. globosa. 

“A complete genomic sequencing of a Malassezia genome opens tremendous opportunities for researchers to understand the interactions of fungi and humans,” said Thomas Dawson, PhD, a scientist at P&G Beauty and the principal author of the PNAS study. “It’s amazing that the understanding of the genetic make-up of a microscopic organism can have broad implications ranging from human health to agricultural science.”

Release date: November 5, 2007

Source: P&G Beauty


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE